Article Details

EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications ...

Retrieved on: 2024-06-24 02:45:20

Tags for this article:

Click the tags to see associated articles and topics

EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications .... View article details on hiswai:

Excerpt

... monoclonal antibodies (mAbs) drug substance facility at Bengaluru. This approval will provide significant additional capacity to address patients ...

Article found on: www.biocon.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo